- Home
- VSEC vs ALVO Comparison
VSEC vs ALVO Comparison
Compare VSEC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEC
- ALVO
- Stock Information
- Founded
- VSEC 1959
- ALVO 2013
- Country
- VSEC United States
- ALVO Luxembourg
- Employees
- VSEC N/A
- ALVO N/A
- Industry
- VSEC Military/Government/Technical
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- VSEC Consumer Discretionary
- ALVO Health Care
- Exchange
- VSEC Nasdaq
- ALVO Nasdaq
- Market Cap
- VSEC 2.7B
- ALVO 2.5B
- IPO Year
- VSEC N/A
- ALVO N/A
- Fundamental
- Price
- VSEC $135.59
- ALVO $9.35
- Analyst Decision
- VSEC Strong Buy
- ALVO Buy
- Analyst Count
- VSEC 6
- ALVO 1
- Target Price
- VSEC $125.17
- ALVO $18.00
- AVG Volume (30 Days)
- VSEC 191.3K
- ALVO 229.9K
- Earning Date
- VSEC 07-30-2025
- ALVO 08-14-2025
- Dividend Yield
- VSEC 0.29%
- ALVO N/A
- EPS Growth
- VSEC N/A
- ALVO N/A
- EPS
- VSEC 0.67
- ALVO 0.34
- Revenue
- VSEC $1,173,794,000.00
- ALVO $587,890,000.00
- Revenue This Year
- VSEC $3.14
- ALVO $35.07
- Revenue Next Year
- VSEC $11.58
- ALVO $44.61
- P/E Ratio
- VSEC $58.11
- ALVO $27.70
- Revenue Growth
- VSEC 40.70
- ALVO 413.92
- 52 Week Low
- VSEC $73.36
- ALVO $7.35
- 52 Week High
- VSEC $140.64
- ALVO $13.79
- Technical
- Relative Strength Index (RSI)
- VSEC 58.81
- ALVO 41.18
- Support Level
- VSEC $131.33
- ALVO $10.32
- Resistance Level
- VSEC $137.82
- ALVO $11.85
- Average True Range (ATR)
- VSEC 3.82
- ALVO 0.46
- MACD
- VSEC -0.27
- ALVO -0.23
- Stochastic Oscillator
- VSEC 57.85
- ALVO 19.87
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.